Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia
A legfontosabb adatok
- Ki végzi
- SPIRE Therapeutics Inc.
- Hol
- Ann Arbor, Manhasset, Minneapolis, Morgantown, New York, Philadelphia, Salt Lake City és St Louis (Egyesült Államok)Mind a 8 helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 180 fő, tervezett
- Kezdés
- 2025. dec. 11.
- Várható befejezés
- 2026. dec.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Focused Ultrasound
- A regiszteradat frissítve
- 2026. augusztus 20.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with fibromyalgia whose pain has not improved with medicines and with physical therapy or CBT (talking therapy). It tests a gentle ultrasound brain stimulation against a fake (sham) treatment.
- Életkor
- 22 years or older
- Nem
- All sexes
- A betegség stádiuma
- Fibromyalgia by the 2016 American College of Rheumatology criteria. Pain in at least 4 of 5 body regions, symptoms for at least 3 months. Pain score of 4 or more on the NRS-11 pain scale at screening and at baseline (averaged over 3 days).
- Korábbi kezelés
- At least two fibromyalgia medicines did not help, and at least 1 of them FDA-approved for fibromyalgia (e.g., pregabalin, duloxetine, milnacipran). At least one try of physical therapy or CBT did not help. Same psychiatric treatment for at least 1 month before screening. No electroconvulsive therapy, transcranial magnetic stimulation, ketamine or esketamine in the past 30 days.
A részvétel fő kizáró okai
- Bipolar disorder, schizophrenia-spectrum disorder, or moderate-high suicide risk
- Moderate or severe alcohol or drug use disorder in the past 6 months
- Progressive nerve disease, cancer-related pain, or autoimmune conditions known to cause pain
- Pregnant or breastfeeding
- Cannot have an MRI, or has implants like pacemakers or neurostimulators
A regiszter feltételei, szó szerint
Mind a 32 feltétel megnézéseKevesebb
Ki vehet részt
- Willing and able to provide informed consent
- Age ≥ 22 years
- Meets 2016 American College of Rheumatology criteria for fibromyalgia:; Generalized pain, defined as pain in at least 4 of 5 regions, is present, AND; Widespread pain index (WPI) ≥ 7 and symptom severity scale score (SSS) ≥ 5, or WPI of 4-6 and SSS score ≥ 9, AND; Symptoms have been present at a similar level for at least 3 months, AND; A diagnosis of fibromyalgia is valid irrespective of other diagnoses. A diagnosis of fibromyalgia does not exclude the presence of other clinically important illnesses
- Failure of at least two evidence-based medications or medications that are commonly used in clinical practice to treat fibromyalgia (e.g., pregabalin, duloxetine, milnacipran, sublingual cyclobenzaprine hydrochloride, tricyclics (e.g., amitriptyline, nortriptyline, desipramine),gabapentin, gabapentinoids, NSAIDS (including Cox-2 inhibitors), acetaminophen, SSRIs, SSNIs, muscle relaxants, non-sublingual forms of cyclobenzaprine hydrochloride, opioids, benzodiazepines), at least 1 of which is FDA-approved for the treatment of fibromyalgia (e.g., pregabalin, duloxetine, milnacipran, and sublingual cyclobenzaprine hydrochloride)
- Failure of one or more attempts at physical or Cognitive Behavioral Therapy (CBT) including:; Aerobic exercise like walking, cycling, and swimming,; Water therapy/hydrotherapy with warm water exercises,; Tai Chi involving slow, controlled movements,; Yoga,; Resistance training,; Bodyweight exercises,; Pilates,; Myofascial release therapy applying gentle pressure on trigger points,; Massage therapy,; Trigger point therapy targeting specific pain points,; Joint mobilization,; Postural retraining to correct body alignment,; Balance and coordination exercises,; Feldenkrais method for movement awareness,; Alexander technique to enhance posture and movement efficiency,; Transcutaneous Electrical Nerve Stimulation (TENS) for pain relief,; Heat therapy using hot packs, infrared, or paraffin wax,; Cold therapy with ice packs or cryotherapy,; Ultrasound therapy for deep tissue relaxation,; Biofeedback to control muscle tension and pain response,; Gentle static stretching for prolonged duration,; Active dynamic stretching for full range of motion,; Proprioceptive Neuromuscular Facilitation (PNF) stretching,; Hydrotherapy pool exercises,; Ai Chi (water-based Tai Chi),; Underwater treadmill therapy, aa) Graded motor imagery (GMI), bb) Mirror therapy to retrain brain-body connections, cc) Mindfulness-based stress reduction (MBSR) combining meditation and movement, dd) Balance exercises to improve stability, ee)Gaze stabilization techniques for dizziness and disorientation, ff) CBT
- Pain score of ≥ 4 on Numerical Rating Scale (NRS-11) at Screening visit
- Pain score of ≥ 4 on NRS-11 at Baseline visit averaged over 3 consecutive calendar days
- Stated willingness and ability to comply with all study procedures
- Has remained on the same psychiatric treatment regimen (e.g., medication, psychotherapy) for at least one (1) month prior to screening, and has stated willingness to remain on the same regimen for the duration of the study unless a change in treatment is recommended or agreed upon by the site investigator
- For participants who could potentially become pregnant: negative urine pregnancy test at screening; agreement to either abstain from heterosexual intercourse or use an acceptable contraceptive method during study participation. Acceptable contraceptive methods include hormonal contraception, including oral contraceptive pills, tubal ligation, vasectomized partner, IUD or IUS (intrauterine device or system), or long-acting reversible contraceptives (LARC)
Ki nem vehet részt
- Any previous diagnosis of bipolar disorder or schizophrenia-spectrum disorder during the participant's lifetime, according to Diagnostic and Statistical Manual of Mental Disorders, version 5 (DSM-5-TR) criteria
- Treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine, or esketamine in the past 30 days
- MRI contraindication or electrically sensitive implants such as pacemakers, implanted cardioverter defibrillators, or neurostimulators. Routine dental hardware is not exclusionary
- Previously enrolled in a DIADEM clinical trial. Note: a patient who screen fails is able to be rescreened at most one time
- New or existing diagnosis of moderate or severe alcohol or other substance use disorder in the past 6 months, according to DSM-5-TR criteria
- New or existing diagnosis of obsessive-compulsive disorder and/or posttraumatic stress disorder in the past 30 days, according to DSM-5-TR criteria, and which is unstable in the clinical judgment of the investigator
- New or existing primary diagnosis of anorexia nervosa, bulimia nervosa, or binge eating disorder in the past 3 months, according to DSM-5-TR criteria
- Clinically significant neurodevelopmental, neurocognitive, or personality disorder, according to DSM-5-TR criteria
- Lifetime history of a serious suicide attempt in the medical opinion of the site investigator
- Currently diagnosed progressive neurological disease such as multiple sclerosis, chronic inflammatory demyelinating polyneuropathy, rapid progressive arachnoiditis, brain or spinal cord tumor, or severe/critical spinal stenosis (stenosis)
- Cancer-related pain
- Diagnosis of malignancy other than basal cell carcinoma, or carcinoma in situ of the cervix within the past five years, to include life expectancy less than one year due to advanced malignancy
- Autoimmune conditions that are known to cause pain
- Inadequately managed general medical condition, in the opinion of the site investigator
- Lifetime history of cerebral small vessel disease
- Lifetime history of intracranial hemorrhage
- Has a history of a medical or psychiatric disorder, disease, condition, injury, symptoms, or circumstance that, in the opinion of the site investigator, may (1) reduce the participant's ability to fulfill the study requirements as per protocol; (2) adversely impact the integrity of the data or the validity of the study results; or (3) pose an increased risk to the participant during study participation
- Moderate-High Risk of Suicide, according to the Columbia-Suicide Severity Rating Scale (C-SSRS) Screen Version - Recent (i.e., answers YES to Question 3 and NO to Question 6 (Moderate Risk), or YES to Question 4, 5, or 6 (High Risk)), or in the clinical judgement of the site investigator
- Changes in prescribed treatments for pain in the past 2 months that could confound study outcome assessments, in the opinion of the site investigator
- Pregnant or breast feeding
- MRI intolerance
- Participants with braids, dreadlocks, or other hairstyles that prevent access to the side of the head and who are unwilling to temporarily adjust their hairstyle to allow such access
Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.
- University of MichiganAnn Arbor, Egyesült ÁllamokContact: Katherine Scott, RN, BSNRésztvevőt keres
- Northwell Health - The Feinstein Institutes of Clinical ResearchManhasset, Egyesült ÁllamokContact: Clinical Research TeamRésztvevőt keres
- University of Minnesota Medical Center, FairviewMinneapolis, Egyesült ÁllamokContact: Eric WilliamsonRésztvevőt keres
- WVU Rockefeller Neuroscience InstituteMorgantown, Egyesült ÁllamokContact: Tami Deal, CCRCRésztvevőt keres
- Icahn School of Medicine at Mount SinaiNew York, Egyesült ÁllamokContact: Maya CampbellRésztvevőt keres
- University of PennsylvaniaPhiladelphia, Egyesült ÁllamokContact: Sean McKenzieRésztvevőt keres
- University of UtahSalt Lake City, Egyesült ÁllamokContact: Rachel Douglas, BS, CCRCRésztvevőt keres
- Washington University in St. LouisSt Louis, Egyesült ÁllamokContact: Cristina Bowman, RNRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical trial is to evaluate a new noninvasive brain stimulation intervention for fibromyalgia and to determine its effectiveness in reducing pain. Participants will receive four treatments over the course of one month and will complete surveys at multiple time points throughout the 16-week study.
A vizsgálat 2 csoportja
- Focused UltrasoundMár használt kezelés, összehasonlításként
- Sham UltrasoundSzínlelt kezelés, összehasonlításként
Kezelés: Focused Ultrasound
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia: A Blinded Randomized Sham-Controlled Trial
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. augusztus 20.